Table 1.

Characteristics of 250 publicly funded substance abuse treatment centers

Variable	N	%
Substance abuse medications prescribed
Any medication	91	37
Buprenorphine	58	24
Methadone	22	9
Tablet naltrexone	42	17
Injectable naltrexone	22	9
Acamprosate	45	19
Disulfiram	39	16
Perceived state policy environment
Support by Single State Agency (SSA) for medicationsa
Supportive of medications for treating substance abuse (M±SD)	2.9±1.0
Has adequately disseminated information about how to implement medication-assisted treatment (M±SD)	2.1±1.2
Has offered sufficient training about using medications to treat substance abuse (M±SD)	1.9±1.2
Scale of SSA support (M±SD)b	2.3±.9
Medicaid formulary includes any medications
Yes	91	37
No	25	10
Don’t know	131	53
State contract funding can be used to purchase medications
Yes	72	28
No	70	29
Don’t know	104	42
Awareness of state funding policies for medications
Neither Medicaid nor state contract funding	128	52
Medicaid but not state contract funding	46	19
State contract funding but not Medicaid	28	11
Both Medicaid and state contract funding	43	18
Organizational characteristics
Government owned	43	17
Located in a hospital or community mental health center	44	18
Accredited by external organization	124	51
Offers detoxification services	48	20
Offers only outpatient treatment	115	47
Physicians on staff (M±SD)	.4±.8
Physicians on contract (M±SD)	.9±1.2
Nurses on staff (M±SD)	1.6±3.8
12-step treatment orientationc	2.3±1.0

^aPossible scores range from 0, strongly disagree, to 4, strongly agree, with greater scores indicating greater SSA support.

^bScale is based on results of the three measures of SSA support for medications; possible scores range from 0 to 4, with higher scores indicating greater SSA support.

^cPossible scores range from 0, strongly inconsistent, to 4, strongly consistent, with greater scores indicating a stronger orientation toward a 12-step treatment model.